Keyphrases
Vedolizumab
100%
Crohn's Disease
99%
Inflammatory Bowel Disease
79%
Ulcerative Colitis
44%
Clinical Remission
39%
Tumor Necrosis Factor Antagonist
36%
Treatment Outcome
27%
Newly Diagnosed
22%
Celiac Disease
21%
Intraepithelial Lymphocytes
20%
Mayo Clinic
20%
Confidence Interval
19%
Villous Architecture
19%
Mucosal Healing
18%
Comparative Safety
17%
Comparative Effectiveness
17%
Duodenal Intraepithelial Lymphocytosis
17%
Ulcerative Colitis Therapy
17%
Memory B Cells
17%
Outcome Prediction
17%
Hazard Ratio
16%
Corticosteroid-Free Remission
15%
Duodenal Biopsy
15%
Disease Activity
14%
Effectiveness Outcomes
14%
Sexual Behavior
14%
Remission
13%
Crohn's
12%
Serious Adverse Events
12%
Corticosteroids
12%
Endoscopic Remission
12%
Crohn's Colitis
11%
Index Score
11%
MRNA Vaccine
11%
Retrospective Cohort Study
11%
Tumor Necrosis Factor-α
10%
Histopathological Features
10%
Response Rate
10%
Adult Crohn's Disease
9%
Gluten-free Diet
9%
Disease Duration
9%
Scoring System
9%
Odds Ratio
9%
Loss of Response
8%
Postmenopausal Women
8%
Activity Improvement
8%
Academic Community
8%
Cerebrovascular Accident
8%
Community Practice
8%
Academic Health System
8%
Medicine and Dentistry
Vedolizumab
91%
Crohn's Disease
76%
Inflammatory Bowel Disease
56%
Ulcerative Colitis
51%
Tumor Necrosis Factor
29%
Coeliac Disease
21%
Patient with Ulcerative Colitis
20%
Adverse Event
20%
Patient with Crohn's Disease
19%
Lymphocytosis
17%
Patient with Inflammatory Bowel Disease
17%
Duodenum Biopsy
15%
Prevalence
14%
Enteric Feeding
13%
Disease
12%
Hazard Ratio
12%
Retrospective Cohort Study
12%
Intraepithelial Lymphocyte
11%
Infection
11%
Granulomatous Colitis
10%
Disease Exacerbation
10%
Odds Ratio
10%
Gluten Free Diet
9%
Disease Duration
9%
Scoring System
9%
Surgery
8%
Memory B Cell
8%
TNF Inhibitor
8%
Endoscopy
8%
Pediatrics Patient
8%
4 Iodo 2,5 Dimethoxyamphetamine
8%
Recurrent Disease
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Psoriasis
8%
Apoplexy
8%
Calciphylaxis
8%
Gastrointestinal Tract
8%
Tumor Necrosis
8%
Clinical Significance
8%
Erectile Dysfunction
8%
Adjuvant Therapy
8%
Breast Cancer Screening
8%
Sarcopenia
8%
Positron Emission Tomography
8%
Breast Cancer
8%
Pustulosis Palmaris Et Plantaris
8%
Fluorodeoxyglucose F 18
8%
Health System
8%
Scabies
8%
Allergen
8%
